Article Details
Retrieved on: 2022-04-27 13:39:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA has granted Breakthrough Therapy Designation to trastuzumab deruxtecan (Enhertu; AstraZeneca) for the treatment of human epidermal growth ...
Article found on: www.pharmacytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here